Rani Therapeutics
San Jose, California, United States · Biotechnology, Healthcare · 88 employees
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designe
Funding history
- Funding Round — $60.3M — Nov 2025
- Funding Round — $50.0M — Nov 2020
- Funding Round — $7.7M — Jun 2015
- Funding Round — $15.5M — Jun 2015
Recent signals
- Nov 10, 2025: Raised $60.3M
- Feb 05, 2025: Launched Rani Therapeutics Unveils Promising Data for Oral Delivery of Semaglutide Using RaniPill® HC, Showcasing Comparable Effectiveness to Injections.
- Nov 16, 2020: Raised $50.0M
- Jun 04, 2015: Raised $7.7M
- Jun 04, 2015: Raised $15.5M
See plans & pricing → Track Rani Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.